Core Insights - Evonik has launched EUDRACAP colon, the first functional ready-to-use capsule material specifically designed for the ileum-colon region, addressing the growing market demand for precise delivery of sensitive active ingredients [1] Group 1: Product Overview - EUDRACAP colon is suitable for delivering sensitive active ingredients such as live biopharmaceuticals, oral biologics, proteins, peptides, and nucleotides [1] - The product aims to facilitate the development of innovative drugs for serious diseases like obesity, AIDS, or cystic fibrosis, as well as for localized delivery in colorectal cancer and infections [1] Group 2: Company Innovation - EUDRACAP colon is the latest innovation in Evonik's oral drug delivery functional capsule platform, which is continuously expanding [1] - The platform also includes EUDRACAP enteric for targeted release in the upper small intestine, EUDRACAP Select for customized CDMO services, and EUDRACAP preclinic for early development stages [1]